{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:28Z","timestamp":1792787848294,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"AOK Bremen Bremerhaven"},{"DOI":"10.13039\/501100007837","name":"Universit\u00e4t Bremen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007837","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Urinary tract infections are among the most common reason for encounter and subsequent antibiotic prescriptions. Due to the risk of collateral damage and increasing resistance rates, explicit recommendations against the use of fluoroquinolones like ciprofloxacin in uncomplicated urinary tract infections have been issued. However, to what extent these recommendations were followed and if there are relevant differences between the disciplines involved (general practitioners, urologists, paediatricians and gynaecologists) are unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used anonymized data from a local statutory health insurance (SHI) company, which covered about 38% of all SHI-insured persons in the federal state of Bremen, Germany between 2015\u20142019. Data included demographics, outpatient diagnoses and filled prescriptions on an individual level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>One-year prevalence of urinary tract infections was 5.8% in 2015 (females: 9.2%, males: 2.5%). Of all 102,715 UTI cases, 78.6% referred to females and 21.4% to males, 6.0% of cases were younger than 18\u00a0years. In females, general practitioners were the most common diagnosing speciality (52.2%), followed by urologists (20.0%) and gynaecologists (16.1%). Overall, fluoroquinolones were most often prescribed (26.3%), followed by fosfomycin (16.1%) and the combination of sulfamethoxazole and trimethoprim (14.2%). Fluoroquinolones were most often prescribed by urologists and general practitioners, while gynaecologists preferred fosfomycin. During the study period, shares of fluoroquinolones decreased from 29.4% to 8.7% in females and from 45.9% to 22.3% in males.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Despite a clear trend toward a more guideline adherent prescription pattern, there is still room for improvement regarding the use of second-line antibiotics especially fluoroquinolones. The choice of antibiotics prescribed differs between specialities with higher uptake of guideline-recommended antibiotics by gynaecologists, mainly because of higher prescription shares of fosfomycin.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12875-022-01816-6","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T23:22:13Z","timestamp":1660173733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Patterns and trends of antibacterial treatment in patients with urinary tract infections, 2015\u20132019: an analysis of health insurance data"],"prefix":"10.1186","volume":"23","author":[{"given":"Guido","family":"Schmiemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Hamprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Jobski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,11]]},"reference":[{"key":"1816_CR1","unstructured":"Dicheva S. Harnwegsinfekte bei Frauen. In: Glaeske G, Schicktanz C, editors. Barmer GEK Arzneimittelreport. 1. ed. Siegburg: Asgard Verlagsservice; 2015. p. 107\u2013137."},{"issue":"639","key":"1816_CR2","doi-asserted-by":"publisher","first-page":"e702","DOI":"10.3399\/bjgp15X686965","volume":"65","author":"CC Butler","year":"2015","unstructured":"Butler CC, Hawking MK, Quigley A, McNulty CA. Incidence, severity, help seeking, and management of uncomplicated urinary tract infection: a population-based survey. Br J Gen Pract J R Coll Gen Pract. 2015;65(639):e702-707.","journal-title":"Br J Gen Pract J R Coll Gen Pract"},{"issue":"4","key":"1816_CR3","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.ijantimicag.2019.06.015","volume":"54","author":"K Malmros","year":"2019","unstructured":"Malmros K, Huttner BD, McNulty C, Rodr\u00edguez-Ba\u00f1o J, Pulcini C, T\u00e4ngd\u00e9n T. Comparison of antibiotic treatment guidelines for urinary tract infections in 15 European countries: Results of an online survey. Int J Antimicrob Agents. 2019;54(4):478\u201386.","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"1816_CR4","doi-asserted-by":"publisher","first-page":"e1002825","DOI":"10.1371\/journal.pmed.1002825","volume":"16","author":"V Hernandez-Santiago","year":"2019","unstructured":"Hernandez-Santiago V, Davey PG, Nathwani D, Marwick CA, Guthrie B. Changes in resistance among coliform bacteraemia associated with a primary care antimicrobial stewardship intervention: A population-based interrupted time series study. PLOS Med. 2019;16(6):e1002825.","journal-title":"PLOS Med"},{"issue":"24","key":"1816_CR5","first-page":"415","volume":"108","author":"FME Wagenlehner","year":"2011","unstructured":"Wagenlehner FME, Hoyme U, Kaase M, F\u00fcnfst\u00fcck R, Naber KG, Schmiemann G. Uncomplicated urinary tract infections. Dtsch \u00c4rztebl Int. 2011;108(24):415\u201323.","journal-title":"Dtsch \u00c4rztebl Int"},{"issue":"3","key":"1816_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000487645","volume":"100","author":"J Kranz","year":"2018","unstructured":"Kranz J, Schmidt S, Lebert C, Schneidewind L, Mandraka F, Kunze M, et al. The 2017 Update of the German Clinical Guideline on Epidemiology, Diagnostics, Therapy, Prevention, and Management of Uncomplicated Urinary Tract Infections in Adult Patients. Part II: Therapy and Prevention. Urol Int. 2018;100(3):271\u20138.","journal-title":"Urol Int"},{"key":"1816_CR7","volume-title":"Management of suspected bacterial lower urinary tract infection in adult women: a national clinical guideline","author":"Scottish Intercollegiate Guidelines Network","year":"2020","unstructured":"Scottish Intercollegiate Guidelines Network. Management of suspected bacterial lower urinary tract infection in adult women: a national clinical guideline. 2020."},{"key":"1816_CR8","unstructured":"European Medicines AgencyMA. Quinolone- and fluoroquinolone-containing medicinal products. European Medicines Agency. 2018. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/quinolone-fluoroquinolone-containing-medicinal-products. Accessed 30 June 2022"},{"key":"1816_CR9","doi-asserted-by":"crossref","unstructured":"Bausch K, Bonkat G. Fluoroquinolone antibiotics \u2013 what we shouldn\u2019t forget two years after the restriction by the European Commission. Swiss Med Wkly. 2022;152:w30126.","DOI":"10.4414\/SMW.2022.w30126"},{"key":"1816_CR10","first-page":"Doc04","volume":"13","author":"J Zweigner","year":"2018","unstructured":"Zweigner J, Meyer E, Gastmeier P, Schwab F. Rate of antibiotic prescriptions in German outpatient care \u2013 are the guidelines followed or are they still exceeded? GMS Hyg Infect Control. 2018;13:Doc04.","journal-title":"GMS Hyg Infect Control"},{"key":"1816_CR11","unstructured":"Bundesministerium f\u00fcr Gesundheit. Mitglieder und Versicherte der Gesetzlichen Krankenversicherung (GKV) https:\/\/www.bundesgesundheitsministerium.de\/themen\/krankenversicherung\/zahlen-und-fakten-zur-krankenversicherung\/mitglieder-und-versicherte.html. Assessed 30 June 2022"},{"key":"1816_CR12","unstructured":"BfArM (Federal Institute for drugs and medical devices) - Tabular list. www.bfarm.de\/EN\/Code-systems\/Classifications\/ICD\/ICD-10-GM\/Tabular-list\/_node.html Assessed 30 June 2022"},{"key":"1816_CR13","unstructured":"WHOCC - ATC\/DDD Index https:\/\/www.whocc.no\/atc_ddd_index\/. Assessed 30 June 2022"},{"key":"1816_CR14","unstructured":"Leitlinienprogramm DGU. Interdisziplin\u00e4re S3 Leitlinie: Epidemiologie, Diagnostik, Therapie, Pr\u00e4vention und Management unkomplizierter, bakterieller, ambulant erworbener Harnwegsinfektionen bei erwachsenen Patienten. 2017. www.awmf.org\/uploads\/tx_szleitlinien\/043-%0A044l_S3_Harnwegsinfektionen.pdf. Assessed 30 June 2022"},{"issue":"1","key":"1816_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12875-021-01470-4","volume":"22","author":"LEA Haugom","year":"2021","unstructured":"Haugom LEA, Ruths S, Emberland KE, Eliassen KER, Rortveit G, Wensaas KA. Consultations and antibiotic treatment for urinary tract infections in Norwegian primary care 2006\u20132015, a registry-based study. BMC Fam Pract. 2021;22(1):127.","journal-title":"BMC Fam Pract"},{"issue":"41","key":"1816_CR16","first-page":"679","volume":"117","author":"J Holstiege","year":"2020","unstructured":"Holstiege J, Schulz M, Akmatov MK, Kern WV, Steffen A, B\u00e4tzing J. The Decline in Outpatient Antibiotic Use. Dtsch Arzteblatt Int. 2020;117(41):679\u201386.","journal-title":"Dtsch Arzteblatt Int"},{"issue":"1","key":"1816_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12875-020-01201-1","volume":"21","author":"A Plate","year":"2020","unstructured":"Plate A, Kronenberg A, Risch M, Mueller Y, Di Gangi S, Rosemann T, Senn O. Treatment of urinary tract infections in Swiss primary care: quality and determinants of antibiotic prescribing. BMC Fam Pract. 2020;21(1):125.","journal-title":"BMC Fam Pract"},{"issue":"3","key":"1816_CR18","doi-asserted-by":"publisher","first-page":"e0214572","DOI":"10.1371\/journal.pone.0214572","volume":"14","author":"HK Isberg","year":"2019","unstructured":"Isberg HK, Hedin K, Melander E, M\u00f6lstad S, Beckman A. Increased adherence to treatment guidelines in patients with urinary tract infection in primary care: A retrospective study. PLOS ONE. 2019;14(3):e0214572.","journal-title":"PLOS ONE"},{"key":"1816_CR19","first-page":"CD003539","volume":"2005","author":"SR Arnold","year":"2005","unstructured":"Arnold SR, Straus SE. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev. 2005;2005:CD003539.","journal-title":"Cochrane Database Syst Rev"},{"key":"1816_CR20","unstructured":"P\u00fcntmann I, Wille H, M\u00fchlbauer B. Bremer Arzneimittelregister (BAR\u00a9) \u2013 Schnelle evidenzbasierte Hilfe bei der t\u00e4glichen Wirkstoffwahl. 2012; www.egms.de\/en\/meetings\/ebm2012\/12ebm081.shtml Assessed 30 June 2022"},{"key":"1816_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2490-12-33","volume":"12","author":"G Schmiemann","year":"2012","unstructured":"Schmiemann G, Gagyor I, Hummers-Pradier E, Bleidorn J. Resistance profiles of urinary tract infections in general practice\u2013an observational study. BMC Urol. 2012;12:33.","journal-title":"BMC Urol"},{"issue":"1","key":"1816_CR22","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1186\/s12879-021-06323-0","volume":"21","author":"AMC Ong Lopez","year":"2021","unstructured":"Ong Lopez AMC, Tan CJL, Yabon AS, Masbang AN. Symptomatic treatment (using NSAIDS) versus antibiotics in uncomplicated lower urinary tract infection: a meta-analysis and systematic review of randomized controlled trials. BMC Infect Dis. 2021;21(1):619.","journal-title":"BMC Infect Dis"},{"key":"1816_CR23","unstructured":"NICE. Urinary tract infection in children: Diagnosis, treatment and long-term management 2013. https:\/\/www.nice.org.uk\/guidance\/cg54. Assessed 30 June 2022"},{"key":"1816_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13756-019-0603-6","volume":"8","author":"E Charani","year":"2019","unstructured":"Charani E, de Barra E, Rawson TM, Gill D, Gilchrist M, Naylor NR, Holmes AH. Antibiotic prescribing in general medical and surgical specialties: a prospective cohort study. Antimicrob Resist Infect Control. 2019;8:151.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"8","key":"1816_CR25","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1093\/jac\/dkz163","volume":"74","author":"V Palin","year":"2019","unstructured":"Palin V, M\u00f6lter A, Belmonte M, Ashcroft DM, White A, Welfare W, van Staa T. Antibiotic prescribing for common infections in UK general practice: variability and drivers. J Antimicrob Chemother. 2019;74(8):2440\u201350.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"1816_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1017\/ice.2019.338","volume":"41","author":"SE Katz","year":"2020","unstructured":"Katz SE, Staub M, Ouedraogo Y, Evans CD, Kainer MA, Griffin MR, Banerjee R. Population-based assessment of patient and provider characteristics influencing pediatric outpatient antibiotic use in a high antibiotic-prescribing state. Infect Control Hosp Epidemiol. 2020;41(3):331\u20136.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"1816_CR27","first-page":"e1","volume":"79","author":"F Hoffmann","year":"2017","unstructured":"Hoffmann F, Koller D. Different Regions, Differently Insured Populations? Socio-demographic and Health-related Differences Between Insurance Funds. Gesundheitswesen. 2017;79(1):e1-9.","journal-title":"Gesundheitswesen"},{"issue":"26","key":"1816_CR28","first-page":"454","volume":"113","author":"J B\u00e4tzing-Feigenbaum","year":"2016","unstructured":"B\u00e4tzing-Feigenbaum J, Schulz M, Schulz M, Hering R, Kern WV. Outpatient Antibiotic Prescription. Dtsch Arzteblatt Int. 2016;113(26):454\u20139.","journal-title":"Dtsch Arzteblatt Int"}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-022-01816-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-022-01816-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-022-01816-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T03:23:26Z","timestamp":1676345006000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-022-01816-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,11]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1816"],"URL":"https:\/\/doi.org\/10.1186\/s12875-022-01816-6","relation":{},"ISSN":["2731-4553"],"issn-type":[{"value":"2731-4553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,11]]},"assertion":[{"value":"25 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For this study, a waiver was obtained from the Medical Ethics Committee of the Carl von Ossietzky University Oldenburg (2022\u2013044). Patient informed consent was not required by German regulations, since this study was based on anonymous data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"GS is author of the German Guideline on urinary tract infections(5), the other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"204"}}